Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS.

Pediatr Nephrol. 2013 Nov;28(11):2097-105. doi: 10.1007/s00467-012-2383-6. Epub 2013 Jan 4. Review.

PMID:
23288350
2.

Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Oakes RS, Kirkham JK, Nelson RD, Siegler RL.

Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9. Erratum in: Pediatr Nephrol. 2008 Nov;23(11):2105. Kirkhamm, Justin K [corrected to Kirkham, Justin K].

PMID:
18465151
3.

[Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].

Bertholet-Thomas A, Ranchin B, King LA, Bacchetta J, Belot A, Gillet Y, Collardeau-Frachon S, Cochat P.

Arch Pediatr. 2011 Jul;18(7):823-30. doi: 10.1016/j.arcped.2011.04.001. Epub 2011 May 14. Review. French.

PMID:
21571510
4.

[Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].

Loirat C.

Rev Prat. 2013 Jan;63(1):11-6. Review. French.

PMID:
23457821
5.

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.

Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF.

JAMA. 2003 Sep 10;290(10):1360-70. Review.

PMID:
12966129
6.

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Scheiring J, Andreoli SP, Zimmerhackl LB.

Pediatr Nephrol. 2008 Oct;23(10):1749-60. doi: 10.1007/s00467-008-0935-6. Epub 2008 Aug 13. Review.

PMID:
18704506
7.

Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.

Derad I, Obermann B, Katalinic A, Eisemann N, Knobloch JK, Sayk F, Wellhöner P, Lehnert H, Solbach W, Süfke S, Steinhoff J, Nitschke M.

Nephrol Dial Transplant. 2016 Jan;31(1):95-103. doi: 10.1093/ndt/gfv255. Epub 2015 Jul 14.

PMID:
26180049
8.

[Hemolytic uremic syndrome: long term renal injury].

Lumbreras Fernández J, Cruz Rojo J, Iñigo Martín G, Muley Alonso R, Vara Martín J.

An Pediatr (Barc). 2010 May;72(5):309-16. doi: 10.1016/j.anpedi.2009.12.016. Epub 2010 Mar 26. Spanish.

9.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
10.

Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1218-28. doi: 10.2215/CJN.08921209. Epub 2010 May 24.

11.

[Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].

Ibarra C, Goldstein J, Silberstein C, Zotta E, Belardo M, Repetto HA.

Arch Argent Pediatr. 2008 Oct;106(5):435-42. doi: 10.1590/S0325-00752008000500011. Review. Spanish.

12.

Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.

Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M.

Am J Transplant. 2013 Aug;13(8):2201-6. doi: 10.1111/ajt.12297. Epub 2013 Jun 3.

13.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
14.

Hemolytic uremic syndrome: defining the need for long-term follow-up.

Small G, Watson AR, Evans JH, Gallagher J.

Clin Nephrol. 1999 Dec;52(6):352-6.

PMID:
10604642
15.

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities.

McCoy N, Weaver DJ Jr.

BMC Pediatr. 2014 Nov 5;14:278. doi: 10.1186/1471-2431-14-278.

16.

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.

Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R; Collaborators of the DGfN STEC-HUS registry.

Nephrol Dial Transplant. 2012 Oct;27(10):3807-15. doi: 10.1093/ndt/gfs394.

PMID:
23114903
17.
18.

Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features.

Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR.

Pediatr Nephrol. 1997 Apr;11(2):156-60.

PMID:
9090653
19.

[Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].

Ito K, Hattori M, Matsumoto N.

Nihon Rinsho. 2002 Jun;60(6):1126-30. Review. Japanese.

PMID:
12078084
20.

Hemolytic uremic syndrome: pathogenesis and update of interventions.

Palermo MS, Exeni RA, Fernández GC.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):697-707. doi: 10.1586/eri.09.49. Review.

PMID:
19681698

Supplemental Content

Support Center